 | |
- close
- close
|
PR Newswire
Dec 1
Comment
THE WOODLANDS, Texas, Dec. 1 /PRNewswire/ -- According to a national poll of oncologists and clinical research professionals, there is a high level of optimism about the potential of clinical trials for personalized medicine. While oncologists view
FierceBiotech
Nov 30
Comment
Over the past year Endo's new CEO, David Holveck (photo), has been steadily shifting the company's focus from pain management to new therapeutic arenas like oncology, doing $900 million worth of deals. And the CEO says he's far from done with the...
Commodity Online
Nov 30
Comment
Platinum based compounds such as cisplatin and oxaliplatin are the cornerstone in the treatment of testicular ovarian colorectal lung and other cancers but their effectiveness is limited by the relatively low therapeutic ratio the ratio of the...
Life Science Lab
Nov 25
Comment
Australian scientists have extracted information that could help us fight certain cancers and autoimmune diseases. Their study of blood samples from patients recovering from bone marrow transplants reveals mechanisms by which certain immune...
FierceBiotech
Nov 24
Comment
Norway's Clavis Pharma has reason to celebrate this morning. The developer has inked a $380 million deal with US-based Clovis Oncology, sending shares up as much as 60 percent, according to Reuters. Clavis will get $15 million up front for...
FierceBiotech
Nov 24
Comment
India's Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute will form a joint venture that will focus on developing affordable treatments for the oncology, metabolic disorders and infectious...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| ||||||
|
|
